AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25028536
Drug: Megace OS
RxNorm normalized name: megestrol acetate Oral Tablet [Megace]
DrugBank: Megestrol acetate (DB00351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megace OS (800 mg/20 mL) in fasting state
Trial: 25028536
Drug: Megace OS
RxNorm normalized name: megestrol acetate Oral Tablet [Megace]
DrugBank: Megestrol acetate (DB00351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megace OS (800 mg/20 mL) in fed state
Trial: 22930542
Drug: Intervention care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention care (multidisciplinary intervention including screening questionnaire, education, pain medication management, physiotherapy-guided exercise, communication with primary care physician)
Trial: 7978433
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg of lyophilized tetracaine with 0.2 mg epinephrine in 2.5 mL 10% dextrose, Group 0: immediately turned supine after spinal injection
Trial: 7978433
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg of lyophilized tetracaine with 0.2 mg epinephrine in 2.5 mL 10% dextrose, Group 6: 6 min in lateral decubitus then supine
Trial: 7978433
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg of lyophilized tetracaine with 0.2 mg epinephrine in 2.5 mL 10% dextrose, Group 12: 12 min in lateral decubitus then supine
Trial: 7978433
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg of lyophilized tetracaine with 0.2 mg epinephrine in 2.5 mL 10% dextrose, Group 18: 18 min in lateral decubitus then supine
Trial: 2568061
Drug: Maintenance treatment
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatment every second week
Trial: 23443764
Drug: Colloid preload
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloid preload with gelofusine at 10 ml·kg(‐1)·h(‐1)
Trial: 23443764
Drug: Colloid preload
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloid preload with gelofusine at 5 ml·kg(‐1)·h(‐1)
Trial: 23443764
Drug: Colloid preload
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloid preload with gelofusine at 15 ml·kg(‐1)·h(‐1)
Trial: 21398038
Drug: Pregabalin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (75 mg twice daily to a maximum of 300 mg twice daily for 28 days)
Trial: 20193529
Drug: micro pump
RxNorm normalized name: EpiQuin Micro Pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: micro pump administration of batroxobin
Trial: 12742333
Drug: Uterine artery
RxNorm normalized name: Sus scrofa artery preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uterine artery Doppler examination and 100 mg aspirin daily from Doppler examination through 36 weeks
Trial: 9146853
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion (20-160 ng kg-1 min-1)
Trial: 9146853
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion with ganglionic blockade (trimetaphan)
Trial: 3218950
Drug: Metoclopramide (MTC)
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoclopramide (MTC) 10 mg IV
Trial: 3218950
Drug: Metopimazine (MTP)
RxNorm normalized name: metopimazine
DrugBank: Metopimazine (DB13591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metopimazine (MTP) 10 mg IV
Trial: 31778823
Drug: GB001 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GB001 5 mg
Trial: 26630400
Drug: PRP +
RxNorm normalized name: Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP + IVR combined treatment
Trial: 18782641
Drug: Exenatide twice
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide twice daily (10 µg)
Trial: 9196108
Drug: Proportional assist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proportional assist ventilation (flow assist = 2 cm H2O/L/s plus volume assist = 4 cm H2O/L)
Trial: 8485793
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg sublingually 20 min before induction of anaesthesia
Trial: 24843712
Drug: Teneligliptin 20
RxNorm normalized name: teneligliptin
DrugBank: Teneligliptin (DB11950)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Teneligliptin 20 mg once daily
Trial: 24014134
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (ongoing antidiabetic therapy)
Trial: 22218402
Drug: Immediate cessation
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate cessation with nicotine patch therapy (2 weeks)
Trial: 22218402
Drug: Reduction approach
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduction approach with either 4 mg nicotine lozenge or ST brand switching
Trial: 18235213
Drug: Metamizole 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metamizole 2 g/8 h i.v. (n = 8)
Trial: 18235213
Drug: Morphine 10
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 10 mg/4 h s.c. (n = 8)
Trial: 15905654
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional physical therapy protocol)
Trial: 10663966
Drug: Kainic acid
RxNorm normalized name: kainic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kainic acid (KA) administration
Trial: 1464075
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg methyl prednisolone (three pulses)
Trial: 2866062
Drug: Beta-adrenoceptor blocking
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-adrenoceptor blocking drugs (atenolol, propranolol, pindolol)
Trial: 2866062
Drug: Propranolol (beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (beta 1- and beta 2-blocker)
Trial: 2866062
Drug: Beta-blockers (atenolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (atenolol, propranolol, pindolol)
Trial: 25863804
Drug: DEB (Drug-Eluting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEB (Drug-Eluting Balloon)
Trial: 18181808
Drug: Sequential anticoagulation
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential anticoagulation (citrate for the first 3.5 h, switching to 30‐min anticoagulation‐free hemodialysis)
Trial: 15902989
Drug: Chokeberry juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chokeberry juice (150 mL daily, containing 23 mg/100 mL of anthocyanins)
Trial: 8948373
Drug: Bovine immunoglobulin
RxNorm normalized name: Bovine immunoglobulin concentrate, cryptosporidium parvum
DrugBank: Cryptosporidium immune globulin (DB17785)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine immunoglobulin concentrate (capsule form)
Trial: 1661057
Drug: High titre
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High titre varicella vaccine (5300 PFU)
Trial: 1661057
Drug: Low titre
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low titre varicella vaccine (2000 PFU)
Trial: 1661057
Drug: Combined varicella
RxNorm normalized name: VARICELLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined varicella and MMR vaccine (high titre)
Trial: 1661057
Drug: Combined varicella
RxNorm normalized name: VARICELLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined varicella and MMR vaccine (low titre)
Trial: 1661057
Drug: Single varicella
RxNorm normalized name: VARICELLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single varicella vaccine (both titre levels)
Trial: 7213522
Drug: Quinidine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (oral and i.v. dosing)
Trial: 7213522
Drug: Quinidine (i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (i.v. dosing)
Trial: 7213522
Drug: Quinidine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (oral dosing)
Trial: 17021748
Drug: Stapled transanal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stapled transanal rectal resection (STARR)
Trial: 19440010
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml lidocaine‐prilocaine cream perianally
Trial: 19440010
Drug: Lidocaine‐prilocaine cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine‐prilocaine cream perianally and intrarectally
Trial: 17045952
Drug: Iron mouthrinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron mouthrinse (10mL of 10mM ferrous sulphate solution) after immersion in cola drink for 5min, followed by brushing after 1min or 30min.
Trial: 17045952
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment after immersion in cola drink.
Trial: 11756369
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (OC) pills
Trial: 7855551
Drug: Clindamycin 6.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin 6.5 mg per kg body weight b.i.d. (children) or 300 mg t.i.d. (adults) for 10 days
Trial: 7855551
Drug: Phenoxymethyl penicillin
RxNorm normalized name: Phenoxymethyl Penicillin
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenoxymethyl penicillin 12.5 mg per kg body weight b.i.d. for 10 days
Trial: 2526622
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (2 micrograms or 0.1 ml) intradermal hepatitis B vaccine
Trial: 2526622
Drug: Standard (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard (20 micrograms or 1 ml) intramuscular hepatitis B vaccine
Trial: 856569
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg reproterol
Trial: 856569
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg orciprenaline
Trial: 31558100
Drug: Dader Method
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dader Method for Pharmaceutical Care (PC)
Trial: 28601627
Drug: 0.2 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 μg/kg dexmedetomidine
Trial: 24073548
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination travoprost 0.004%/timolol 0.5%
Trial: 24073548
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination dorzolamide 2%/timolol 0.5%
Trial: 19180530
Drug: Brief self-administered
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief self-administered psychological intervention
Trial: 9830258
Drug: typical antipsychotic
RxNorm normalized name: benzocaine Mucous Membrane Topical Solution [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: typical antipsychotic medication
Trial: 7973751
Drug: Conservative and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative and functional treatment with AIRCAST pneumatic leg braces, including a lower leg cast for 2 weeks followed by mobilization with protection from the brace.
Trial: 2689314
Drug: Pulmo-Timelets (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmo-Timelets (600 mg theophylline)
Trial: 2689314
Drug: Theophylline controlled-release
RxNorm normalized name: theophylline Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline controlled-release tablet (600 mg theophylline)
Trial: 30366361
Drug: Genetically predicted
RxNorm normalized name: Burosumab (genetical recombination)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genetically predicted circulating vitamin K₁ levels (per 1 nmol/L increase)
Trial: 26822714
Drug: UC‐II (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UC‐II (40 mg daily)
Trial: 26822714
Drug: GC (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GC (1500 mg G & 1200 mg C)
Trial: 20542554
Drug: Allopurinol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (600 mg per day)
Trial: 16085238
Drug: Aggressive combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive combined modality treatment arm for patients with poor prognosis
Trial: 14989462
Drug: Enzyme replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzyme replacement therapy (ERT) with agalsidase alfa for 6 months
Trial: 10579146
Drug: Sirolimus administered
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus administered after a high-fat meal (15 mg single dose)
Trial: 10579146
Drug: Sirolimus administered
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus administered while fasting (15 mg single dose)
Trial: 1899644
Drug: Continuous release
RxNorm normalized name: B Compound Continuous Release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous release transdermal nitroglycerin (group 1)
Trial: 1899644
Drug: Discontinuous release
RxNorm normalized name: morphine sulfate Extended Release Oral Tablet [MST Continus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuous release transdermal nitroglycerin (group 2)
Trial: 6179617
Drug: Adriamycin during
RxNorm normalized name: Adriamycin
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adriamycin during induction of remission and maintenance therapy
Trial: 31476539
Drug: Buccal‐based triangular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal‐based triangular flap (Group 1)
Trial: 23506407
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of four dental implants with a fixed prosthesis (experimental arm)
Trial: 22832126
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment at 66 µg/kg/day
Trial: 19650603
Drug: Oral-B Advantage
RxNorm normalized name: Advantage Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-B Advantage 123
Trial: 12412826
Drug: Zomacton 4
RxNorm normalized name: Zomacton
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zomacton 4 mg/ml conventional syringe administration (Treatment A)
Trial: 12412826
Drug: Zomacton 10
RxNorm normalized name: ZOMACTON 10mg Powder for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zomacton 10 mg/ml conventional syringe administration (Treatment B)
Trial: 12412826
Drug: Zomacton 10
RxNorm normalized name: ZOMACTON 10mg Powder for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zomacton 10 mg/ml ZomaJet 2 Vision administration (Treatment C)
Trial: 10212734
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of emotional, organic and neuropsychological measures (Hospital Anxiety and Depression Scale, Impact of Event Scale, Short Orientation Memory and Concentration Test, Rivermead Post‐Concussion Symptoms Questionnaire, Post‐Traumatic Amnesia) taken at 7‐10 days post-injury
Trial: 30385451
Drug: Finger prick
RxNorm normalized name: prickly pear fruit extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finger prick autologous blood (FAB) treatment
Trial: 26542271
Drug: PT (Physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PT (Physical Therapy) 3 times/week for 4 weeks
Trial: 25138681
Drug: Transdermal contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal contraceptive patch applied to buttocks
Trial: 25138681
Drug: Transdermal contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal contraceptive patch applied to outer upper arm
Trial: 25138681
Drug: Transdermal contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal contraceptive patch applied to lower abdomen
Trial: 25138681
Drug: Transdermal contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal contraceptive patch applied to any site
Trial: 19908948
Drug: Carisoprodol 250
RxNorm normalized name: carisoprodol 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carisoprodol 250 mg
Trial: 15378438
Drug: Tafenoquine 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tafenoquine 400 mg (base) daily for 3 days, followed by single monthly 400-mg doses (n = 104)
Trial: 11162345
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment condition
Trial: 2485152
Drug: Cyclooxygenase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclooxygenase inhibitors (azapropazone) and aprotinin
Trial: 2485152
Drug: Non-steroidal antiphlogistic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal antiphlogistic drugs
Trial: 1148993
Drug: Low-dose preoperative
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose preoperative irradiation (2000-2500 rads/10 fractions/12 days)
Trial: 1148993
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose preoperative irradiation (3150 rads)
Trial: 22476244
Drug: Glucosamine sulfate
RxNorm normalized name: Glucosamine Sulfate
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine sulfate (1,500 mg/day) plus exercise therapy
Trial: 19502478
Drug: Individual‐Based Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual‐Based Treatment (IBT)
Trial: 16861432
Drug: Positive intravascular
RxNorm normalized name: acellular tissue engineered vessel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive intravascular fluid balance of 0-1000 mL (Group 1)
Trial: 16861432
Drug: Positive intravascular
RxNorm normalized name: acellular tissue engineered vessel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive intravascular fluid balance of 1000-2000 mL (Group 2)
Trial: 12942587
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (IB) 500 mg
Trial: 8767376
Drug: Mechanical lavage
RxNorm normalized name: lovage oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical lavage with 2 l of polyethylene glycol (PEG) solution combined with a laxative (group A, n = 50)
Trial: 8767376
Drug: Lavage with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lavage with 4 l of PEG alone (group B, n = 50)
Trial: 6752563
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg dimethpyrindene (Fenistil) and 5 mg/kg cimetidine (Tagamet)
Trial: 6752563
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg dimethpyrindene and 10 mg/kg cimetidine
Trial: 6752563
Drug: H1- +
RxNorm normalized name: Histamine H1 Receptor Agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H1- + H2-receptor antagonists
Trial: 31800611
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine (30 mg) before surgery
Trial: 28286194
Drug: Rectal tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal tacrolimus (0.5 mg/mL)
Trial: 23031464
Drug: E2 (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2 (125 mg PFA/kg BD)
Trial: 23031464
Drug: E3 (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E3 (250 mg PFA/kg BD)
Trial: 11448249
Drug: Clonidine (4,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (4, 6, and 8 mcg/kg/day)
Trial: 30479242
Drug: Collaborative shared
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Collaborative shared care (CSC) program between traditional and faith healers (T&FHs) and biomedical providers for the treatment of psychotic disorders
Trial: 28189771
Drug: Tiotropium 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 5 μg (2 puffs of 2.5 μg)
Trial: 28189771
Drug: Tiotropium 2.5
RxNorm normalized name: TIOTROPIUM 2.5MCG/ACTUAT 60D ORAL INHL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 2.5 μg (2 puffs of 1.25 μg)
Trial: 25915834
Drug: Topical EBI-005
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical EBI-005 (5 mg/mL)
Trial: 23635736
Drug: Individually tailored
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individually tailored therapy (n=62)
Trial: 18385391
Drug: Niacinamide (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacinamide (500 to 1500 mg/d)